Angiopro GmbH
Globally connected.
Locally present.
Cardiovascular medicine needs partners who understand clinical practice. Angiopro has been exactly that for more than 30 years. With medical devices and software for interventional cardiology, Structural Heart and vascular surgery.
Position
Clinical precision is not a promise.
It is the starting point.
In cardiovascular medicine, there is no room for compromise. Every product in the portfolio stands for a clearly defined indication, regulatory approval and clinical validation. This standard applies to every market and every partner worldwide.
Present in more than 85 countries
Clinics and partners on six continents. Without regional restrictions.
For cardiologists, cardiac surgeons and vascular surgeons
Products for the cath lab. Designed for demanding indications.
Medical devices for cardiovascular intervention
Coronary intervention, Structural Heart and vascular surgery. Every product for a clearly defined indication.
Clinical software for planning and analysis
Preoperative planning, quantitative imaging analysis and 3D cardiac diagnostics. Regulatory approved, clinically validated.
Portfolio
Two product areas. One clinical focus.
Angiopro supplies clinics with medical devices for coronary intervention, Structural Heart and vascular surgery. From calcium modification prior to stent implantation to high pressure balloon catheters in the TAVR setting and balloon expandable aortic stents. Every product for a clearly defined indication.
View medical devicesThe software portfolio covers preoperative planning solutions for Structural Heart procedures and EVAR treatment, quantitative coronary analysis without pressure wire and echocardiography based 3D cardiac diagnostics. Regulatory approved, proven in international centres.
View softwareAngiopro in numbers
Specialising in cardiovascular medicine for more than three decades.
Clinics and partners worldwide. Present on six continents.
Global presence in cardiovascular care.
Contact
Contact for clinics and partners
Enquiries about products, approvals, delivery terms and collaborations are answered directly.